Castle Biosciences, Inc. Common Stock CSTL
Key Stats
- Today's Range
- $27.50 – $30.81
- 50-Day Range
- $18.91 – $30.81
- 52-Week Range
- $14.59 – $44.28
- Volume
- 1.76 million shs
- Average Volume
- 419K shs
- Market Cap
- $855.39 million
- P/E Ratio
- —
- Dividend Yield
- —
Valuation
- P/E Ratio
- —
- Price / Book
- 1.82
- Price / Sales
- 2.39
Short Interest
- Short Interest
- 0.05%
- Days to Cover
- 1.00
Financials (TTM)
- Revenue
- $357.28 million
- Net Income
- $-19,415,000
- Net Margin
- -5.43%
- Return on Equity
- -4.13%
- Debt-to-Equity
- 0.02
About Castle Biosciences, Inc. Common Stock
Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. The company derives revenues through the delivery of test reports for its molecular diagnostic tests.
Related Stocks
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.